Breaking AI & Tech News Analyzed

The LeadOpenAI says its new general‑purpose reasoning model has produced an original proof that disproves the famous geometry conjecture posed by Paul Erdős in 1946, ending an 80‑year open problem.OpenAI Announces Disproof of Erdős’s 1946 Geometry ConjectureThe company released a pre‑print and companion remarks signed by mathematicians Noga Alon, Melanie Wood and Thomas Bloom. The proof introduces a completely new family of constructions that outperform the long‑standing “square‑grid” belief.Timeline of Claims and CorrectionsJuly 2025: Former VP Kevil Weil tweeted that “GPT‑5 found solutions to 10 unsolved Erdős problems”.Later 2025: Critics including Yann LeCun and Demis Hassabis called the claim a misrepresentation; Weil removed the post.May 20, 2026: OpenAI publishes the new disproof, backed by external experts.Why This Disproof Could Redefine AI‑Driven ResearchThe breakthrough demonstrates that an AI system can autonomously manage long, intricate chains of reasoning and synthesize ideas across mathematical sub‑fields, a capability that researchers argue could translate to breakthroughs in biology, physics, engineering and medicine.What Comes Next for AI in Fundamental ScienceExperts anticipate a surge in AI‑assisted exploration of other long‑standing conjectures. If the model’s reasoning can be generalized, we may see a new era where AI acts as a co‑discoverer rather than a tool.

Executive Overview: IrisGo’s Vision for a Proactive Desktop CompanionIrisGo is positioning itself as the next‑generation “AI desktop buddy,” a software agent that anticipates and executes user tasks before they are explicitly requested. By combining on‑device learning with selective cloud processing, the startup promises a privacy‑first, hands‑free workflow for knowledge workers.Seed Funding and Strategic Backers Power IrisGo’s LaunchThe company closed a $2.8 million seed round earlier this year, led by Andrew Ng’s AI Fund. Additional capital and credibility come from Nvidia, Google, and a strategic OEM partnership with Acer, which will pre‑install the app on new laptops.Financial Snapshot: $2.8 Million Seed Round and Early PartnershipsFunding amount: $2.8 million seed roundLead investor: AI Fund (Andrew Ng)Key backers: Nvidia, GoogleOEM deal: Acer (beta pre‑install)Launch timeline: macOS and Windows beta released May 2026Industry Implications: Shifting the Burden of Repetitive Tasks from Knowledge Workers to AI AgentsThe platform’s “skills” library—covering email drafting, invoice processing, report generation, and code assistance—targets white‑collar employees who spend a large portion of their day on repetitive actions. By executing these tasks autonomously, IrisGo could reduce operational overhead, accelerate decision‑making, and set a new baseline for AI‑augmented productivity tools.Future Outlook: From Beta to Pre‑installed Desktop StandardWith beta feedback flowing and an OEM pipeline forming, IrisGo’s roadmap includes:Expanding the skills catalog to cover industry‑specific workflowsScaling hybrid on‑device/cloud architecture while maintaining end‑to‑end encryptionSecuring additional pre‑install agreements with major laptop manufacturersLaunching a subscription model for enterprise teams by late 2026If adoption accelerates, IrisGo could become a default component of modern workstations, reshaping how software interacts with human intent.

Keir Starmer announced a £3.7bn trade agreement with the six Gulf Cooperation Council (GCC) states, calling it a “huge win” for British business after four years of negotiations spanning four prime ministers.Starmer Secures £3.7bn GCC Trade Deal After Four Years of NegotiationsThe agreement, signed on 20 May 2026, removes tariffs on 93% of British goods sold to Saudi Arabia, Kuwait, Oman, Qatar, the United Arab Emirates and Bahrain. It follows earlier pacts with India and South Korea and is presented as the most significant agricultural deal since Brexit.Financial Upside: £3.7bn in Export Opportunities and Tariff EliminationsThe government estimates the deal will generate £3.7bn of export opportunities – double the original forecast – across food, luxury cars, defence, aerospace, hospitality and other services.Zero tariffs on: food, medical equipment, defence, aerospace, advanced manufacturing.Current tariffs removed: 5% blanket duty on most GCC imports; specific rates previously applied to cheddar cheese (6%), chocolate (15%), biscuits (10%) and cars (5%).Data‑storage: GCC states will allow UK firms to store data outside the region for the first time.Political and Human‑Rights Controversies Surrounding the DealCritics, including the Trade Justice Movement’s Tom Wills, argue the omission of a human‑rights chapter is “especially alarming” given documented abuses in the Gulf. Paul Nowak of the Trade Unions Congress called the agreement “disappointing” in light of the region’s record on workers’ rights. The government says political channels, not trade texts, are the preferred venue for addressing such concerns.Implications for UK Industries and Future Trade StrategyThe National Farmers Union hails the deal as the best agricultural arrangement since the EU exit, while the British Chambers of Commerce expects new business for firms in financial services, energy, construction, professional services, education, hospitality and technology. William Bain, head of trade policy at the BCC, stresses the pact’s potential to benefit “tens of thousands of UK firms.” Investor‑protection clauses have raised worries about future litigation over policy shifts, such as Heathrow expansion.Outlook: How the GCC Pact May Shape Britain’s Trade LandscapeBeyond immediate revenue, the agreement signals the UK’s intent to be the first G7 nation with a “modern and ambitious” GCC deal, potentially encouraging further Gulf investment in UK assets like Heathrow and Newcastle Football Club. The political window created for Starmer may influence upcoming domestic debates, while the lack of human‑rights provisions could shape future negotiations with other non‑EU partners.

Jhonatan Narváez secured his third stage win of the 2026 Giro d’Italia by out‑sprinting Enric Mas on the final climb of stage 11, as Afonso Eulálio held onto the overall lead.Stage 11 Showdown: Narváez Beats Mas on the Final ClimbThe 195km route from Porcari to Chiavari featured three categorized climbs. After a lively breakaway, the peloton regrouped and a 12‑man group surged ahead on the second climb, gaining over three minutes on the main field. On the uncategorized climb before the finish, Mas launched an attack, but Narváez responded and held him off to the line.Winner: Jhonatan Narváez (UAE Team Emirates XRG)Runner‑up: Enric Mas (Movistar)Third place: Diego Ulissi (XDS Astana)Stage distance: 195kmNumbers on the Road: Time Gaps and Stage StatsThe breakaway group finished more than 3 minutes ahead of the peloton that contained all GC contenders. Afonso Eulálio kept his 27‑second advantage over race favourite Jonas Vingegaard in the general classification.Implications for the General ClassificationWith the pink jersey unchanged, the battle for overall victory remains focused on the upcoming mountain stages. Mas, a three‑time Vuelta runner‑up, is now out of contention for the overall win, while the GC group will look to limit losses before the next decisive climbs.Looking Ahead: What Stage 12 Holds for the Pink JerseyStage 12 is a flat 175km ride from Imperia to Novi Ligure. The route offers a chance for sprinters but also a strategic window for teams protecting the leader to control any breakaways and preserve Eulálio's lead.

During the Russia‑China summit on 20 May 2026, Presidents Vladimir Putin and Xi Jinping announced a shared understanding on the main parameters of the Power of Siberia 2 (POS‑2) pipeline – its route through western Siberia, Mongolia and into China, and the construction approach. Detailed commercial terms remain unresolved.Summit Consensus on Route and Construction of POS‑2The leaders confirmed agreement on the pipeline’s alignment and the technical framework, but emphasized that pricing, financing and a detailed timetable still need to be finalised.Pipeline Capacity and Economic Scale Compared to Global BenchmarksThe proposed line will span roughly 2,600 km (1,616 mi) and transport up to 50 billion cubic metres (1.77 trillion cubic feet) of natural gas per year, equivalent to about 525 TWh – almost twice the United Kingdom’s annual electricity consumption. For perspective:Nord Stream 1 capacity: 55 bcm/yrPOS‑1 reached full capacity in 2024 after construction began in 2014Estimated project horizon: up to 10 years from construction start to full outputGeopolitical and Market Ramifications for Russia and ChinaFor Russia, POS‑2 offers a new outlet for gas previously destined for Europe, helping Gazprom recoup revenue lost after the 2022 sanctions. The pipeline also promises multiplier effects for Russian steel and construction firms.For China, the line reduces dependence on seaborne LNG that must navigate chokepoints such as the Strait of Hormuz and the Strait of Malacca, providing a more secure, lower‑cost supply and shielding the market from geopolitical volatility.Outlook: Timeline, Pricing Negotiations and Energy Market ShiftsNegotiations are stalled primarily over price – China seeks rates linked to its heavily subsidised domestic gas, while Russia aims for terms closer to those of POS‑1. No definitive timetable has been set. Analysts project that, if an agreement is reached, the pipeline could begin deliveries in the early 2030s, reshaping global gas flows by:Cutting China’s future LNG import demandSoftening Atlantic‑based LNG price pressuresAccelerating a regionalised gas market centred on long‑term bilateral contractsNevertheless, both sides face risks: Russia may become a price‑taker to a single customer, and China could over‑concentrate supply from a politically volatile partner.

The Funding Crisis The Board of Peace, which was founded by United States President Donald Trump in January to oversee the administration and reconstruction of the Gaza Strip, is facing a crippling cash crunch that threatens to derail its ambitious $70bn reconstruction plan for the devastated enclave. The US-led board recently reported a critical gap between its financial commitments and actual disbursements, warning of an urgent liquidity crisis, according to the Reuters news agency. The Structure of the Board However, experts tracking international aid to Palestinians said the funding shortfall is neither surprising nor purely administrative. Instead, they argued that the reluctance of Arab and European donors stems from the board’s controversial structure, a lack of a viable political horizon for a Palestinian state and Israel’s ongoing military expansion across the besieged enclave. Moath al-Amoudi, an expert in international aid to Palestinians, told Al Jazeera that the heavily publicised pledges are closer to a “talk show” than a genuine humanitarian effort. A History of Empty Promises “Out of the $17bn pledged, the actual liquidity that has reached the ground is zero,” al-Amoudi said. “Donors are terrified of engaging with a board that carries no political vision and treats Gaza merely as an American security protectorate.” The gap between pledges and actual disbursements is a historical constant in the Palestinian context, but the US has a particularly poor track record, al-Amoudi noted. Commercial Guardianship and the $1bn Seats Much of the international hesitation is rooted in the architecture of the Board of Peace itself. Previous Al Jazeera reporting revealed that the board operates as a complex three-tiered governing structure heavily stacked with American billionaires and pro-Israel figures, such as billionaire Marc Rowan, US envoy Steve Witkoff, Secretary of State Marco Rubio and Trump son-in-law Jared Kushner. Humanitarian Aid as Political Blackmail The board’s funding crisis is deeply intertwined with its strict political and security conditions. The three-phased US plan for Gaza explicitly demands the full disarmament of Hamas and all allied Palestinian factions as a prerequisite for reconstruction funds and the opening of border crossings while Israel has continued to violate the terms of an October “ceasefire”. The Yellow Line and Modern Ghettos Beyond the political and structural flaws of the board, the volatile reality on the ground makes meaningful reconstruction nearly impossible. Despite a nominal “ceasefire”, Israeli forces have continued their near-daily violations. According to local medical sources, 828 Palestinians have been killed since the “truce” went into effect.

Early‑stage evidence from a University of Bristol randomised controlled trial suggests that the anti‑inflammatory drug tocilizumab may improve symptoms in patients with moderate‑to‑severe depression who have not responded to standard antidepressants.Trial Overview: Testing Tocilizumab for Treatment‑Resistant DepressionThe study examined whether blocking the IL‑6R receptor could alleviate depressive symptoms. Key design elements:Participants: 30 adults with moderate‑to‑severe depression unresponsive to conventional medication.Intervention: Intravenous tocilizumab versus placebo.Duration: four‑week double‑blind period.Outcomes measured: depression severity, fatigue, state anxiety, and quality of life.Key Numbers: Sample Size, Remission Rates, and NNTAlthough the trial was not powered to reach statistical significance, observed trends were notable:Depression remission: 54% in the tocilizumab group vs 31% in the placebo group.Number Needed to Treat (NNT): 5, meaning five patients would need treatment for one additional remission.For comparison, the NNT for first‑line SSRIs is approximately 7.The lack of robust statistical proof reflects the small cohort, underscoring the need for larger studies.Potential Shift in Depression Treatment ParadigmsResearchers describe the trial as an “important milestone” because it is:One of the first randomised trials to test immunotherapy for depression.The inaugural study targeting the IL‑6R pathway in this context.A proof‑of‑concept for selecting patients based on biological markers.Given that up to one‑third of depressed patients do not improve with existing pharmacotherapies, a biologically driven approach could expand therapeutic options and move psychiatry toward more personalised care.What Comes Next: Larger Studies and Clinical ImplicationsThe investigators plan to:Conduct larger, multi‑centre trials to confirm efficacy and safety.Explore longer treatment durations and dosage optimisation.Assess whether IL‑6R blockade can be combined with existing antidepressants.If subsequent trials replicate these findings, immunotherapy could become a viable adjunct or alternative for treatment‑resistant depression, potentially reshaping clinical guidelines and drug development pipelines.

The Last-Minute Labor AgreementNew York City hotel operators and unions have successfully negotiated an eight-year labor deal covering approximately 25,000 workers, effectively averting a strike that had threatened to disrupt the city just before the FIFA World Cup. According to Vijay Dandapani, president and chief executive of the Hotel Association of New York City, the mood among owners was "overall positive" after weeks of intense negotiations, though the industry made significant concessions to reach the agreement.Key Terms of the Historic DealThe comprehensive agreement addresses critical issues including wages, workloads, and staffing levels that had been points of contention between hotel operators and workers. Dandapani emphasized that "we came a long way from where things were," highlighting the substantial progress made during negotiations. The deal comes at a crucial time as the United States prepares to cohost the FIFA World Cup with Canada and Mexico from June 11 to July 19, with the prospect of an influx of international visitors raising the stakes for all parties involved.Financial Implications for the IndustryWhile the exact financial terms weren't fully disclosed, Dandapani mentioned that a figure of about $200,000 reflected compensation at the end of the agreement, not at the outset. Hotel owners had entered the talks aiming to preserve profitability, citing that New York's lodging market has not fully recovered from the pandemic. Occupancy remains below 2019 levels, and inflation-adjusted room rates have yet to catch up, creating significant financial pressure on the industry.Broader Industry Pressures and ContextThe negotiations took place against a backdrop of multiple challenges facing the hospitality industry. Dandapani cited broader pressures including the US-Israel war on Iran, tariffs, and visa issues that are affecting tourism and operations. The potential strike was considered a "very real threat," especially with recent labor actions in other major US cities including Los Angeles and Boston. The deal follows the withdrawal of a proposed city measure that operators said would have sharply raised labor costs by limiting room attendants' workloads and requiring double pay beyond certain thresholds. Owners estimated this measure could have lifted wage costs by about 40 percent.Future Outlook for NYC HospitalityAlthough the new pact will still add costs to hotel operations, industry leaders expect tourism demand and major events like the FIFA World Cup to support revenue growth in the coming years. The eight-year agreement provides stability for both workers and management, allowing for long-term planning in an industry still recovering from pandemic disruptions. With the World Cup approaching and other major events on the horizon, New York City's hospitality sector appears positioned to navigate the challenges ahead while maintaining service standards for visitors.

The Growing Ebola Crisis in Central AfricaThe World Health Organization (WHO) has confirmed a significant increase in Ebola cases, reporting 600 suspected cases with 139 deaths in the Democratic Republic of Congo (DRC) and Uganda. This outbreak, declared a public health emergency of international concern, has emerged just five months after the DRC's previous epidemic was declared over.The Emergency Response and Risk AssessmentDuring an Emergency Committee meeting in Geneva, WHO Director-General Tedros Adhanom Ghebreyesus confirmed that the virus remains a public health emergency of international concern, but not a pandemic emergency. "The WHO assess the risk of the epidemic as high at the national and regional levels and low at the global level," Tedros stated.WHO emergencies chief Chikwe Ihekweazu emphasized that the organization's "absolute priority now is to identify all the existing chains of transmission" to define the outbreak's scale and provide appropriate care.Rising Case Numbers and Geographic SpreadPrevious figures reported by DRC officials indicated 131 deaths from 513 suspected cases, showing a significant increase in both cases and fatalities. Of the 600 suspected cases, 51 have been confirmed in the DRC's northern provinces of Ituri and North Kivu.The outbreak has crossed borders, with Uganda confirming two cases in Kampala, including one death, from individuals who traveled from the DRC. A medical missionary who contracted Ebola in the DRC is also being transported to Germany for treatment.The Challenge of the Bundibugyo StrainHealth authorities have identified the Bundibugyo strain as the cause of this outbreak, a particularly concerning development as no vaccine or treatment currently exists for this variant of the Ebola virus. This strain was first identified in Uganda in 2007 and has caused previous outbreaks with high fatality rates.WHO experts believe the outbreak began a few months ago, with the first suspected death reported on April 20. Following this initial death, officials suspect a super-spreader event occurred at either a funeral or healthcare facility, though investigations are ongoing to confirm the exact circumstances.Regional and Global ImplicationsThe outbreak presents significant challenges for the already fragile healthcare systems in the DRC and neighboring Uganda. The declaration of a public health emergency of international concern mobilizes global resources and attention to contain the spread.On the global front, a European Union spokesperson has stated that the risk of an outbreak in Europe is "very low," emphasizing that while "diseases do not stop at the borders," there is no indication that Europeans need to take extraordinary measures beyond standard health advice.Path Forward in Containing the OutbreakWith the WHO's emergency declaration, international health organizations and local authorities are working to implement containment strategies. The focus remains on identifying transmission chains, providing care for those affected, and preventing further spread across borders.The situation remains fluid, with health officials closely monitoring developments in both affected countries. The international community's response will be crucial in determining whether this outbreak can be contained before it escalates further.